Endothelial Dysfunction and Fetuin A Levels Before and After Kidney Transplantation
Authors:
- Kayser CaglarKCKayser Caglar
- Mahmut Ilker YilmazMYMahmut Ilker Yilmaz
- Mutlu SaglamMSMutlu Saglam
- Erdinc CakirECErdinc Cakir
- Selim KilicSKSelim Kilic
- Tayfun EyiletenTETayfun Eyileten
- Alper SonmezAlper Sonmez
- Yusuf OguzYOYusuf Oguz
- Koksal OnerKOKoksal Oner
- Fatih OrsFOFatih Ors
- Abdulgaffar VuralAVAbdulgaffar Vural
- Mujdat YenicesuMYMujdat Yenicesu
- 1 February 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 83 (4) , 392-397
Abstract
Endothelial dysfunction (ED) has a major role in the cardiovascular outcome of patients with chronic kidney disease (CKD). The aim of this study was to investigate the relation between fetuin A levels and ED in kidney transplant recipients. Forty-two living donor kidney transplant recipients, 21 (11 male) on cyclosporine A and 21 (10 male) on tacrolimus-based regimes, were studied. Forty-two (21 male) healthy subjects were enrolled as controls. Fetuin A, highly sensitive C-reactive protein (hsCRP) levels, brachial artery endothelium-dependent vasodilatation (FMD), nitroglycerine mediated dilatation (NMD), and carotid intima-media thickness (CIMT) were measured before transplantation and on the 30th and 90th days posttransplant. Pretransplantation serum fetuin A concentrations and FMD values of patients were significantly lower than those of the controls (P<0.001 for both). These were significantly increased in the 30th and 90th days posttransplantation There was a significant positive correlation between Fetuin A and FMD levels both before and after kidney transplantation (r=0.534, r=0.576; respectively, P<0.001 for both). Carotid intima-media thickness and hsCRP levels decreased after transplantation (P<0.001 for all). According to the regression analysis, fetuin A, intact parathyroid hormone, and hsCRP levels were the independent determinants of FMD. The results of the present study suggest that low serum fetuin A levels in CKD may contribute to impaired endothelial functions in CKD. Future studies should clarify the role of fetuin A levels in cardiovascular outcomes of CKD.Keywords
This publication has 29 references indexed in Scilit:
- Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul studyNephrology Dialysis Transplantation, 2006
- Enhanced Coronary Calcification Determined by Electron Beam CT Is Strongly Related to Endothelial Dysfunction in Patients With Suspected Coronary Artery DiseaseChest, 2005
- Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuinKidney International, 2005
- Vascular calcification in patients with end-stage renal diseaseNephrology Dialysis Transplantation, 2004
- Natural history of vascular calcification in dialysis and transplant patientsNephrology Dialysis Transplantation, 2004
- Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis PatientsJournal of the American Society of Nephrology, 2004
- The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcificationJournal of Clinical Investigation, 2003
- Structural Basis of Calcification Inhibition by α2-HS Glycoprotein/Fetuin-AJournal of Biological Chemistry, 2003
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial DysfunctionCirculation, 2000